21. Access to novel drugs for non-small cell lung cancer in Central and Southeastern Europe : a Central European Cooperative Oncology Group analysisTanja Čufer, Tudor Ciuleanu, Peter Berzinec, Gabriela Galffy, Marko Jakopović, Jacek Jassem, Dragana Jovanovic, Zhasmina MIhaylova, Gyula Ostoros, Christiane Thallinger, Milada Zemanova, Christoph Zielinski, 2020, original scientific article Abstract: Background. Treatment of non-small cell lung cancer (NSCLC) improved substantially in the last decades. Novel targeted and immune-oncologic drugs were introduced into routine treatment. Despite accelerated development and subsequent drug registrations by the European Medicinal Agency (EMA), novel drugs for NSCLC are poorly accessible in Central and Eastern European (CEE) countries. Material and Methods. The Central European Cooperative Oncology Group conducted a survey among experts from 10 CEE countries to provide an overview on the availability of novel drugs for NSCLC and time from registration to reimbursement decision in their countries. Results. Although first-generation epidermal growth factor receptor tyrosine kinase inhibitors were reimbursed and available in all countries, for other registered therapies - even for ALK inhibitors and checkpoint inhibitors in first-line - there were apparent gaps in availability and/or reimbursement. There was a trend for better availability of drugs with longer time from EMA marketing authorization. Substantial differences in access to novel drugs among CEE countries were observed. In general, the availability of drugs is not in accordance with the Magnitude of Clinical Benefit Scale (MCBS), as defined by the European Society for Medical Oncology (ESMO). Time spans between drug registrations and national decisions on reimbursement vary greatly, from less than 3 months in one country to more than 1 year in the majority of countries. Conclusion. The access to novel drugs for NSCLC in CEE countries is suboptimal. To enable access to the most effective compounds within the shortest possible time, reimbursement decisions should be faster and ESMO MCBS should be incorporated into decision making.
Keywords: non-small cell lung cancer, treatment, novel drugs, Central Europe, Southeastern Europe
Published in DiRROS: 24.07.2020; Views: 1876; Downloads: 1087
 Full text (341,24 KB)
This document has many files! More... |
22. Cultural ecosystem services provided by the biodiversity of forest soils : a European reviewJurga Motiejunaite, Isabella Børja, Ivika Ostonen, Mark Bakker, Brynhildur Bjarnadottir, Ivano Brunner, Reda Iršenaite, Tanja Mrak, Edda Oddsdottir, Tarja Lehto, 2019, original scientific article Abstract: Soil is one of the most species-rich habitats and plays a crucial role in the functioning of terrestrial ecosystems. It is acknowledged that soils and their biota deliver many ecosystem services. However, up to now, cultural ecosystem services (CES) provided by soil biodiversity remained virtually unknown. Here we present a multilingual and multisubject literature review on cultural benefits provided by belowground biota in European forests. We found 226 papers mentioning impact of soil biota on the cultural aspects of human life. According to the reviewed literature, soil organisms contribute to all CES. Impact on CES, as reflected in literature, was highest for fungi and lowest for microorganisms and mesofauna. Cultural benefits provided by soil biota clearly prevailed in the total of the reviewed references, but there were also negative effects mentioned in six CES. The same organism groups or even individual species may have negative impacts within one CES and at the same time act as an ecosystem service provider for another CES. The CES were found to be supported at several levels of ecosystem service provision: from single species to two or more functional/taxonomical groups and in some cases morphological diversity acted as a surrogate for species diversity. Impact of soil biota on CES may be both direct % by providing the benefits (or dis-benefits) and indirect through the use of the products or services obtained from these benefits. The CES from soil biota interacted among themselves and with other ES, but more than often, they did not create bundles, because there exist temporal fluctuations in value of CES and a time lag between direct and indirect benefits. Strong regionality was noted for most of CES underpinned by soil biota: the same organism group or species may have strong impact on CES (positive, negative or both) in some regions while no, minor or opposite effects in others. Contrarily to the CES based on landscapes, in the CES provided by soil biota distance between the ecosystem and its CES benefiting area is shorter (CES based on landscapes are used less by local people and more by visitors, meanwhile CES based on species or organism groups are used mainly by local people). Our review revealed the existence of a considerable amount of spatially fragmented and semantically rich information highlighting cultural values provided by forest soil biota in Europe.
Keywords: soil biota, forests, soil ecosystem services, Europe
Published in DiRROS: 20.02.2020; Views: 1828; Downloads: 1032
Full text (329,19 KB)
This document has many files! More... |
